SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE414.70-0.85 (-0.2 %)
PREV CLOSE ( ) 415.55
OPEN PRICE ( ) 416.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 414.70 (437)
VOLUME 274378
TODAY'S LOW / HIGH ( )411.65 421.50
52 WK LOW / HIGH ( )350.4 678.8
NSE414.85-0.9 (-0.22 %)
PREV CLOSE( ) 415.75
OPEN PRICE ( ) 416.95
BID PRICE (QTY) 414.85 (226)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3886561
TODAY'S LOW / HIGH( ) 411.55 421.50
52 WK LOW / HIGH ( )344.55 679.3
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
20Apr Sun Pharmaceutical Industries submits
Sun Pharmaceutical Industries has submitted the Shareholding Pattern for..
11Apr Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed about the disclosure under Re..
11Apr Pratham Investments informs about disc
Pratham Investments has informed about the disclosure under Regulation 3..
09Apr Sun Pharma's arm to commence distribut
Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Dis..
09Apr Sun Pharma trades in green on the BSE
Sun Pharmaceutical Industries is currently trading at Rs. 464.50, up by..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit-386.8-4945.9
Gross Profit -650.7 -5199.8
Operating Profit 2023.712510.6
Net Sales 22612.679476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
NGL Fine-Chem (BSE)
 538.80 (20.00%)
M.Cap (Rs. in Cr)332.87
Abbott India (BSE)
 8001.75 (0.93%)
M.Cap (Rs. in Cr)17003.16
SMS Lifesciences (BSE)
 498.40 (9.89%)
M.Cap (Rs. in Cr)150.68
Sanofi India (BSE)
 5440.40 (0.82%)
M.Cap (Rs. in Cr)12529.58
Pfizer (BSE)
 3187.10 (1.19%)
M.Cap (Rs. in Cr)14580.26
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 12.76%
MUTUAL FUNDS/UTI 9.31%
FI/BANKS/INSURANCE 7.8%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.